Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, April 16, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Next-Generation Therapeutics for Infectious Diseases Conquer the Global Spotlight
Resistance to current drugs spurs treatment innovation in influenza, respiratory syncytial virus, chlamydia and gonorrhea.
MIT Chemists Devise Novel Way to Manufacture Peptide Drugs
New, fast synthetic method enables manufacture of peptides in hours, which could boost drug development.
VolitionRx’s NuQ® Assays Demonstrate 80% Detection Rate in Prostate Cancer
Study data also demonstrates ability to distinguish between prostate and colorectal cancer.
Optimising Vaccine Process Scale up of Attachment Dependent Cells using Micro Bioreactors and Microcarriers
Performing microcarrier culture using an automated microscale bioreactor system offers a method of improved process development for production of vaccine using attachment dependent cells.
Testosterone-Regulated Genes May Affect Vaccine-Induced Immunity
NIH-funded study helps explain differences in male and female responses to vaccines.
NIH Program Bridges Gap to Develop New Therapeutics
New projects advance treatments for acute radiation syndrome, brain injury from cardiac arrest and a rare blood disorder.
FDA Approves First Generic Versions of Antidepressant Drug Cymbalta
The U.S.FDA approved the first generic versions of Cymbalta), a prescription medicine used to treat depression and other conditions.
Bridgepoint Development Capital to Acquire Quotient Clinical
Quotient Clinical has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum.
UConn Chemist Discovers New Way to Stabilize Proteins
Discovery could lead to the development of stable vaccines and affordable artificial blood substitutes.
'Smuggling' Drugs at the Cellular Level
Drexel researchers use ultrasound to deliver customized medication through the skin.
Scroll Up
Scroll Down
Return
Public Funding for Academic Bioprocessing Research in the UK
Ben Sykes, BBSRC, speaking at Stem Cells & Bioprocessing Europe 2012.
Date Posted: Monday, April 08, 2013
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



New Way to Improve Antibiotic Production
A discovery has been made which could make it easier to scale up antibiotic production for commercialisation.
Tuesday, June 18, 2013
BBSRC is Major Partner in Europe-wide Synthetic Biology Funding
BBSRC is contributing €3M as a major partner in a new call for research projects in Synthetic Biology.
Tuesday, May 14, 2013
H7N9: A Novel Influenza Virus and it’s Control
Whilst the virus remains as one primarily circulating in birds, breaking this cycle of replication is the only effective response to its control.
Thursday, May 09, 2013
BBSRC Supports Call for Multi-Disciplinary Research Centres in Synthetic Biology
Up to six centres will be funded in two phases; three in this financial year and three next financial year.
Friday, May 03, 2013
Vaccine Production in Plants Nets Scientist Innovator of the Year 2012
Innovation could allow quicker vaccine development to combat pandemics.
Friday, March 30, 2012
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv